These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2436030)
1. [Raynaud syndrome and changes in lung function as sequelae of cytostatic therapy of testicular tumors]. Creutzig A; Pölking W; Schmoll HJ; Fabel H; Alexander K Med Klin (Munich); 1987 Feb; 82(4):131-4. PubMed ID: 2436030 [No Abstract] [Full Text] [Related]
2. [Raynaud's disease after treatment with bleomycin and vinblastine]. Dzieza-Lalowicz I; Mykała-Cieśla J Pol Tyg Lek; 1986 Feb; 41(7):218-9. PubMed ID: 2423995 [No Abstract] [Full Text] [Related]
3. Raynaud's phenomenon and cryoglobulinemia during chemotherapy for testicular carcinoma. Dunlop PR; Hendy-Ibbs PM Cancer Treat Rep; 1983 Mar; 67(3):317-8. PubMed ID: 6187453 [No Abstract] [Full Text] [Related]
4. [Raynaud's phenomenon following combined cytostatic treatment of malignant testicular tumours]. Scheulen ME; Schmidt CG Dtsch Med Wochenschr; 1982 Oct; 107(43):1640-4. PubMed ID: 6183087 [TBL] [Abstract][Full Text] [Related]
6. Raynaud's phenomenon as a side effect of chemotherapy with vinblastine and bleomycin for testicular carcinoma. Teutsch C; Lipton A; Harvey HA Cancer Treat Rep; 1977 Aug; 61(5):925-6. PubMed ID: 70274 [No Abstract] [Full Text] [Related]
7. Raynaud's phenomenon after vinblastine-bleomycin chemotherapy. Rothberg H; Varney JK J Med Soc N J; 1978 Nov; 75(12):845-6. PubMed ID: 81878 [No Abstract] [Full Text] [Related]
11. Treatment results of stage III germinal testicular tumors. Akdaş A; Kirkali Z; Altuğ U; Ilker Y Turk J Pediatr; 1984; 26(1-4):301-6. PubMed ID: 6085662 [No Abstract] [Full Text] [Related]
12. Raynaud's phenomenon after vinblastine-bleomycin chemotherapy. Rothberg H Cancer Treat Rep; 1978 Apr; 62(4):569-70. PubMed ID: 77726 [No Abstract] [Full Text] [Related]
13. Testicular dysfunctions in patients after cytostatic treatment of non-seminomatous testis tumours. Ondrus D; Vrabec J Czech Med; 1986; 9(1):34-7. PubMed ID: 2423304 [TBL] [Abstract][Full Text] [Related]
14. Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens? Bokemeyer C J Clin Oncol; 2008 Apr; 26(11):1783-5. PubMed ID: 18398143 [No Abstract] [Full Text] [Related]
15. Transient left homonymous hemianopsia during treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin. Crispino S; Pizzocaro G; Solero CL; Rodari A; Monfardini S Chemioterapia; 1984 Oct; 3(5):337-9. PubMed ID: 6085288 [TBL] [Abstract][Full Text] [Related]
16. Raynaud phenomenon in three patients with acquired immune deficiency syndrome-related Kaposi sarcoma treated with bleomycin. von Gunten CF; Roth EL; Von Roenn JH Cancer; 1993 Sep; 72(6):2004-6. PubMed ID: 7689922 [TBL] [Abstract][Full Text] [Related]
17. Vinblastine, cisplatin and bleomycin (VPB) adjuvant therapy does not induce dose-dependent damage in human chromosomes. Gundy S; Baki M; Bodrogi I Neoplasma; 1989; 36(4):457-64. PubMed ID: 2475796 [TBL] [Abstract][Full Text] [Related]
18. Erectile dysfunction with chemotherapy. van Basten JP; van Driel MF; Hoekstra HJ; Sleijfer DT Lancet; 2000 Jul; 356(9224):169. PubMed ID: 10963279 [No Abstract] [Full Text] [Related]
19. [Pulmonary side effects of bleomycin therapy]. Andler W Klin Padiatr; 1984; 196(1):47-8. PubMed ID: 6198554 [TBL] [Abstract][Full Text] [Related]
20. Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer. Stefenelli T; Kuzmits R; Ulrich W; Glogar D Eur Heart J; 1988 May; 9(5):552-6. PubMed ID: 2456930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]